• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎——麻醉科医生和重症监护医生应该了解些什么?

COVID-19 - what should anaethesiologists and intensivists know about it?

作者信息

Wujtewicz Magdalena, Dylczyk-Sommer Anna, Aszkiełowicz Aleksander, Zdanowski Szymon, Piwowarczyk Sebastian, Owczuk Radoslaw

机构信息

Department of Anaesthesiology and Intensive Therapy, Medical University of Gdańsk, Gdańsk, Poland.

Students' Scientific Society at the Medical University of Gdańsk, Gdańsk, Poland.

出版信息

Anaesthesiol Intensive Ther. 2020;52(1):34-41. doi: 10.5114/ait.2020.93756.

DOI:10.5114/ait.2020.93756
PMID:32191830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10173133/
Abstract

Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.

摘要

在过去三个月里,世界面临着前所未有的健康危机。世界卫生组织宣布出现了一种由名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的未知冠状病毒引起的大流行感染。该病毒主要通过飞沫传播,在大多数病例中会引起轻微症状,最常见的症状有:发热(80%)、干咳(56%)、乏力(22%)和肌肉疼痛(7%);较不常见的症状包括咽痛、流涕、腹泻、咯血和寒战。SARS-CoV-2感染的一种危及生命的并发症是急性呼吸窘迫综合征(ARDS),在老年人、免疫功能紊乱者和有合并症者中更常发生。严重的感染形式,即入住重症监护病房进行治疗的指征,包括急性肺部炎症、ARDS、脓毒症和脓毒性休克。本文介绍了有关该感染的病因、发病机制和诊断(特别强调计算机断层成像的重要性)、临床表现、治疗和预防的基本信息。文章接着强调了提供麻醉和重症监护服务的特定风险。由于尚未有有效的病因治疗方法,且感染和死亡人数日益增加,预防感染和严格遵守感染控制组织的建议仍然是抗击该病毒的基础。

相似文献

1
COVID-19 - what should anaethesiologists and intensivists know about it?新型冠状病毒肺炎——麻醉科医生和重症监护医生应该了解些什么?
Anaesthesiol Intensive Ther. 2020;52(1):34-41. doi: 10.5114/ait.2020.93756.
2
A Review of Coronavirus Disease-2019 (COVID-19).新型冠状病毒肺炎(COVID-19)概述。
Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.
3
Diarrhoea: An Atypical Presentation of COVID-19.腹泻:新型冠状病毒肺炎的一种非典型表现
J Coll Physicians Surg Pak. 2020 Jun;30(6):40-42. doi: 10.29271/jcpsp.2020.Supp1.S40.
4
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
5
Neonatal intensive care unit preparedness for the Novel Coronavirus Disease-2019 pandemic: A New York City hospital perspective.新生儿重症监护病房应对2019年新型冠状病毒病大流行的准备情况:纽约市一家医院的视角
Curr Probl Pediatr Adolesc Health Care. 2020 Apr;50(4):100795. doi: 10.1016/j.cppeds.2020.100795. Epub 2020 May 14.
6
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].[2019冠状病毒病及严重急性呼吸综合征冠状病毒2的诊断、治疗、控制与预防:回归未来]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):571-592. doi: 10.13345/j.cjb.200115.
7
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
8
Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.关于成人新型冠状病毒肺炎继发急性呼吸衰竭患者无创呼吸支持的临床共识推荐
Med Intensiva (Engl Ed). 2020 Oct;44(7):429-438. doi: 10.1016/j.medin.2020.03.005. Epub 2020 Mar 30.
9
[Covid-19 in patients on dialysis: infection prevention and control strategies].[透析患者中的新型冠状病毒肺炎:感染预防与控制策略]
G Ital Nefrol. 2020 Apr 9;37(2):2020-vol2.
10
Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari "Aldo Moro" in Italy.用于 SARS-CoV-2、SARS-CoV、MERS-CoV 和 HCoV 大流行冠状病毒科家族成员的快速和敏感的多重检测的诊断程序:越南范周仁大学与意大利巴里大学“阿尔多·莫罗”之间的转化研究与合作。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7173-7191. doi: 10.26355/eurrev_202006_21713.

引用本文的文献

1
The COVID-19 pandemic through the lens of the Anaesthesiology Intensive Therapy journal: What have we learned?从《麻醉与重症治疗杂志》视角看新冠疫情:我们学到了什么?
Anaesthesiol Intensive Ther. 2025 Apr 15;57(1):66-69. doi: 10.5114/ait/203440.
2
Soluble Urokinase Plasminogen Activator Receptor: A Useful Marker for Predicting Mortality in COVID-19 Patients.可溶性尿激酶型纤溶酶原激活物受体:预测COVID-19患者死亡率的有用标志物。
Cureus. 2024 Nov 25;16(11):e74438. doi: 10.7759/cureus.74438. eCollection 2024 Nov.
3
FEASIBILITY STUDY ON SWALLOWING TELEREHABILITATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019.2019年冠状病毒病患者吞咽远程康复的可行性研究
J Rehabil Med Clin Commun. 2023 Jun 5;6:12348. doi: 10.2340/jrmcc.v6.12348. eCollection 2023.
4
Identification of phytochemical compounds of and their targets by metabolomics, network pharmacology and molecular docking studies.通过代谢组学、网络药理学和分子对接研究鉴定[具体物质]的植物化学化合物及其靶点。
Heliyon. 2023 Mar;9(3):e14029. doi: 10.1016/j.heliyon.2023.e14029. Epub 2023 Mar 1.
5
Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial "The EXER-COVID Crossover Study".COVID-19 出院后症状患者的阻力训练和临床状况:一项随机对照交叉试验“EXER-COVID 交叉研究”的方案。
Trials. 2022 Aug 9;23(1):643. doi: 10.1186/s13063-022-06608-y.
6
Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2.治疗由冠状病毒SARS-CoV-2引发的细胞因子释放综合征的当前策略
Immunotargets Ther. 2022 May 18;11:23-35. doi: 10.2147/ITT.S360151. eCollection 2022.
7
Oropharyngeal dysphagia telerehabilitation in the Intensive Care Unit for COVID-19: a case report.COVID-19 重症监护室患者的口咽吞咽障碍远程康复治疗:病例报告。
Codas. 2022 Apr 1;34(6):e20210023. doi: 10.1590/2317-1782/20212021023. eCollection 2022.
8
Elements and COVID-19: A Comprehensive Overview of Studies on Their Blood/Urinary Levels and Supplementation with an Update on Clinical Trials.元素与新型冠状病毒肺炎:关于其血液/尿液水平及补充剂研究的全面概述并更新临床试验情况
Biology (Basel). 2022 Jan 28;11(2):215. doi: 10.3390/biology11020215.
9
Assessment of COVID-19 Fear in Five European Countries before Mass Vaccination and Key Predictors among Nurses and Nursing Students.欧洲五个国家大规模疫苗接种前对 COVID-19 的恐惧评估以及护士和护理专业学生中的关键预测因素
Vaccines (Basel). 2022 Jan 10;10(1):98. doi: 10.3390/vaccines10010098.
10
COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies.加勒比地区2019冠状病毒病大流行的遏制:病例管理与公共卫生策略综述
AIMS Public Health. 2021 Sep 27;8(4):665-681. doi: 10.3934/publichealth.2021053. eCollection 2021.

本文引用的文献

1
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore.为应对 COVID-19 大流行做准备:对新加坡一家大型教学医院手术室疫情应对措施的回顾。
Can J Anaesth. 2020 Jun;67(6):732-745. doi: 10.1007/s12630-020-01620-9. Epub 2020 Mar 11.
2
Respiratory support for patients with COVID-19 infection.新型冠状病毒肺炎(COVID-19)感染患者的呼吸支持
Lancet Respir Med. 2020 Apr;8(4):e18. doi: 10.1016/S2213-2600(20)30110-7. Epub 2020 Mar 5.
3
What we do when a COVID-19 patient needs an operation: operating room preparation and guidance.当新冠病毒肺炎患者需要进行手术时我们的做法:手术室准备与指导。
Can J Anaesth. 2020 Jun;67(6):756-758. doi: 10.1007/s12630-020-01617-4. Epub 2020 Mar 6.
4
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.血管紧张素转换酶2(ACE2)作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的受体:分子机制与潜在治疗靶点
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.
5
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
6
Laboratory abnormalities in patients with COVID-2019 infection.2019冠状病毒病感染患者的实验室异常情况。
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. doi: 10.1515/cclm-2020-0198.
7
Outbreak of a new coronavirus: what anaesthetists should know.新型冠状病毒爆发:麻醉医生应了解的事项。
Br J Anaesth. 2020 May;124(5):497-501. doi: 10.1016/j.bja.2020.02.008. Epub 2020 Feb 27.
8
Coronavirus 2019-nCoV: A brief perspective from the front line.新型冠状病毒 2019-nCoV:来自前线的简要观察。
J Infect. 2020 Apr;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010. Epub 2020 Feb 25.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.